Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection.

Publication Type:

Journal Article


American journal of obstetrics and gynecology, Volume 200, Issue 5, p.489.e1-8 (2009)


2009, Adolescent, Adult, Biopsy, Case-Control Studies, Center-Authored Paper, Cervical Intraepithelial Neoplasia, Contraceptive Agents, Female, Contraceptives, Oral, Combined, Delayed-Action Preparations, Female, Humans, Medroxyprogesterone Acetate, Middle Aged, Papillomavirus Infections, Public Health Sciences Division, Risk Factors, Tumor Virus Infections, Uterine Cervical Neoplasms, Young Adult


The objective of the study was to examine the relationship of depot-medroxyprogesterone acetate (DMPA) and combined oral contraceptive (COC) use with cervical intraepithelial neoplasia (CIN).